JOSÉ LUIS
CABRIADA NUÑO
Ikertzailea 2022-(e)ra arte
Hospital Universitario Son Espases
Palma, EspañaHospital Universitario Son Espases-ko ikertzaileekin lankidetzan egindako argitalpenak (16)
2024
-
Combination of granulocyte–monocyte apheresis and tofacitinib: Multicentre and retrospective study
Gastroenterologia y Hepatologia, Vol. 47, Núm. 7, pp. 727-733
-
Combination of granulocyte–monocyte apheresis and ustekinumab: Multicentre and retrospective study
Gastroenterologia y Hepatologia
-
Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry
Alimentary Pharmacology and Therapeutics, Vol. 60, Núm. 5, pp. 604-612
2023
-
Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated with Internal Fistulizing Disease: BIOSCOPE Study from GETECCU
American Journal of Gastroenterology, Vol. 118, Núm. 6, pp. 1036-1046
2022
-
Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (J. Clin. Med., (2021), 10, (2885), 10.3390/jcm10132885)
Journal of Clinical Medicine
-
Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry
Journal of Clinical Medicine, Vol. 11, Núm. 2
-
Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case–Control Study (COVID-19-EII)
Journal of Clinical Medicine, Vol. 11, Núm. 24
2021
-
Incidence, clinical characteristics and management of inflammatory bowel disease in spain: Large-scale epidemiological study
Journal of Clinical Medicine, Vol. 10, Núm. 13
2019
-
EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain
Therapeutic Advances in Gastroenterology, Vol. 12
-
Granulocyte–monocyte apheresis: an alternative combination therapy after loss of response to anti-TNF agents in ulcerative colitis
Scandinavian Journal of Gastroenterology, Vol. 54, Núm. 4, pp. 459-464
2018
-
Addition of granulocyte/monocyte apheresis to oral prednisone for steroid-dependent ulcerative colitis: A Randomized multicentre clinical trial
Journal of Crohn's and Colitis, Vol. 12, Núm. 6, pp. 687-694
-
Granulocyte and monocyte apheresis in inflammatory bowel disease: The patients’ point of view
Gastroenterologia y Hepatologia, Vol. 41, Núm. 7, pp. 423-431
2012
-
Leukocytapheresis for steroid-dependent ulcerative colitis in clinical practice: Results of a nationwide Spanish registry
Journal of Gastroenterology, Vol. 47, Núm. 4, pp. 359-365
2011
-
Post-marketing health technology monitoring. The analysis of an experience from a clinical perspective
Frontiers in Pharmacology, Vol. JUL
2008
-
Tuberculous chemoprophylaxis requirements and safety in inflammatory bowel disease patients prior to anti-TNF therapy
Inflammatory Bowel Diseases, Vol. 14, Núm. 10, pp. 1387-1391
2006
-
Consensus document on the use of granulocytapheresis in patients with inflammatory bowel disease
Gastroenterologia y Hepatologia, Vol. 29, Núm. 2, pp. 85-92